Vicarious Surgical (NYSE:RBOT – Get Free Report) is anticipated to release its earnings data after the market closes on Monday, March 17th. Analysts expect Vicarious Surgical to post earnings of ($2.75) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Vicarious Surgical Price Performance
Shares of RBOT opened at $9.17 on Monday. The company has a market capitalization of $54.15 million, a price-to-earnings ratio of -0.89 and a beta of 1.35. Vicarious Surgical has a fifty-two week low of $4.27 and a fifty-two week high of $19.00. The business’s 50-day moving average is $13.29 and its 200-day moving average is $10.49.
Wall Street Analyst Weigh In
Separately, Piper Sandler dropped their price objective on Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a report on Wednesday, November 13th.
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Featured Stories
- Five stocks we like better than Vicarious Surgical
- Conference Calls and Individual Investors
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Do ETFs Pay Dividends? What You Need to Know
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
